Get the Stockscreener App
0.4278
6.36%
0.0256
Organovo Holdings Inc stock is traded at $0.4278, with a volume of 197.38K.
It is up +6.36% in the last 24 hours and up +10.83% over the past month.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
See More
Previous Close:
$0.4022
Open:
$0.4259
24h Volume:
197.38K
Relative Volume:
0.03
Market Cap:
$8.40M
Revenue:
-
Net Income/Loss:
$-19.09M
P/E Ratio:
-0.1971
EPS:
-2.17
Net Cash Flow:
$-16.92M
1W Performance:
-5.06%
1M Performance:
+10.83%
6M Performance:
-21.07%
1Y Performance:
-56.79%
1-Day Range:
$0.4075
$0.4305
1-Week Range:
$0.3916
$0.4692
52-Week Range:
$0.3154
$1.83
Organovo Holdings Inc Stock (ONVO) Company Profile
Name
Organovo Holdings Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Compare ONVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONVO
Organovo Holdings Inc
|
0.4278 | 8.40M | 0 | -19.09M | -16.92M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
508.13 | 130.68B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
678.38 | 74.97B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.43 | 36.08B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.07 | 31.19B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.39 | 27.56B | 3.32B | -860.46M | -1.04B | -8.32 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Organovo Holdings Inc Stock (ONVO) Latest News
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Matinas BioPharma Lands Organovo Chairman, Pharma Veteran in Strategic Board Revamp - StockTitan
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises - The Manila Times
Organovo Holdings Inc: Is ONVO Stock Worth Buying? - Stocks Register
ONVO’s Q2 earnings estimates: What investors need to know - US Post News
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Top Biotech Stocks To Follow TodayFebruary 25th - MarketBeat
Organovo’s FXR program to be acquired by Eli Lilly - MSN
Human Organoids Market Research Report 2025 | Now AvailableGlobal Forecasts to 2030 - GlobeNewswire
Is Eli Lilly Stock Outperforming the Nasdaq? - TradingView
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor - Quantisnow
Eli Lilly to acquire Organovo’s FXR program - MSN
3d Printing For Medical Sector Market Generated Opportunities, - openPR
Investor Network: Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Global Human Liver Model Market 2025-2030: Growth Driven by 3D Bioprinting & Liver Disease Research - GlobeNewswire Inc.
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.43% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.43% - Investing.com UK
WWE Revenue Dip Amid ‘Raw’ Shift To Netflix Squeezes Endeavor-Run TKO’s Q4 Results, But Numbers Still Top Wall Street Forecasts - Yahoo Finance UK
Promising Small Cap Stocks To Follow NowFebruary 25th - MarketBeat
Large owner Lilly Endowment Inc sold $203,190,794 worth of shares (225,000 units at $903.07), decreasing direct ownership by 0.23% to 96,236,978 units (SEC Form 4) - Quantisnow
G20 leaders warn declining cooperation threat to global stability - Yahoo Finance UK
Keir Starmer’s defence pledge will prompt ‘tough choices’ on tax - Yahoo Finance UK
Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum - openPR
Shadow Chancellor slams inheritance tax changes as an “absurdity” - Yahoo Finance UK
Eli Lilly and Company entered into an asset purchase agreement to acquire FXR Program and Related Assets of Organovo Holdings, Inc. for $60 million. - Marketscreener.com
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion - Quantisnow
Record year for UniCredit bank sees top banker's pay rise by a third - Yahoo
IGA seeks garage owners’ input ahead of key MOT fee meeting - Yahoo News
Indonesia agrees deal with Apple that could end iPhone sales ban - Yahoo Finance UK
Australian Vintage unveils new wine range amid mixed half-year results - Yahoo
Hong Kong pledges $127.67 million to create AI institute - Yahoo
BP unveils multi-billion-dollar deal to redevelop Iraq's oil fields - Yahoo
Stellantis says 2024 profits fall 70% on N. America troubles - Yahoo Finance UK
Porsche names new CFO and sales chief in bid to revive performance - Yahoo Finance UK
Aston Martin cuts 170 jobs as losses, debt balloon - Yahoo Finance UK
M&A News: Eli Lilly (LLY) Expands IBD Pipeline with Organovo’s FXR Program - TipRanks
This Biotech Stock Ripped Following Program Acquisition Announcement - The Globe and Mail
Why Eli Lilly Stock Popped Today - sharewise
Organovo Offloads FXR Agonist Portfolio To Lilly - Scrip
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings - Benzinga
Biotech Stock Organovo Holdings (Nasdaq: ONVO) Soars on Eli Lilly (NYSE: LLY) Deal - Investorideas.com newswire
Organovo up 270% on FXR program deal with Lilly - The Pharma Letter
This craft chain is closing nationwide, including in Grand Junction - Yahoo News
Top Midday Gainers -February 25, 2025 at 01:48 pm EST - Marketscreener.com
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast - Benzinga
Trinidad and Tobago to seek US licence extension for Dragon gas project in Venezuela - Yahoo
Organovo Holdings Inc Stock (ONVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):